Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13743166 | 0.80 | GAA (0.35) | GAAL3MBTL1HTT | |
| SCHEMBL13958207 | 0.80 | GAA (0.35) | GAAL3MBTL1HTT | |
| SCHEMBL13849314 | 0.80 | — | — | |
| SCHEMBL7628924 | 0.78 | — | — | |
| SCHEMBL12259035 | 0.77 | GAA (0.46) | GAAL3MBTL1HTT | |
| SCHEMBL7631741 | 0.75 | GAA (0.47) | GAAL3MBTL1 | |
| SCHEMBL18560467 | 0.75 | GAA (0.44) | GAAL3MBTL1HTT | |
| SCHEMBL271984 | 0.75 | GAA (0.44) | GAAL3MBTL1HTT | |
| SCHEMBL18501489 | 0.74 | — | — | |
| SCHEMBL696671 | 0.73 | GAA (0.43) | GAAL3MBTL1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103650-A1 | THERMALLY STABLE COMPOSITIONS AND USE THEREOF AS ANTIFOULANTS | ECOLAB USA INC. (US) | 2026-04-16 | — | — | US | claimed |
| US-20260103650-A1 | THERMALLY STABLE COMPOSITIONS AND USE THEREOF AS ANTIFOULANTS | ECOLAB USA INC. (US) | 2026-04-16 | — | — | US | disclosed |
| EP-3898566-B1 | HYDROXYLATED QUINONE ANTIPOLYMERANTS AND METHODS OF USING | ECOLAB USA INC (US) | 2024-12-11 | — | — | EP | disclosed |
| US-11866631-B2 | Oxygenated aminophenol compounds and methods for preventing monomer polymerization | ECOLAB USA INC. (US) | 2024-01-09 | — | — | US | disclosed |
| EP-3820846-B1 | COMPOSITION FOR INHIBITING MONOMER POLYMERIZATION COMPRISING A NITROXIDE INHIBITOR, A QUINONE METHIDE RETARDER AND AN AMINE STABILIZER | ECOLAB USA INC (US) | 2024-01-03 | — | — | EP | disclosed |
| EP-4028382-B1 | QUINONE METHIDE AND AMMONIUM SALT ANTIPOLYMERANT COMPOSITION AND METHOD | ECOLAB USA INC (US) | 2023-11-22 | — | — | EP | disclosed |
| US-11396629-B2 | Quinone methide and ammonium salt antipolymerant composition and method | ECOLAB USA INC. (US) | 2022-07-26 | — | — | US | disclosed |
| EP-4028382-A1 | QUINONE METHIDE AND AMMONIUM SALT ANTIPOLYMERANT COMPOSITION AND METHOD | Ecolab USA Inc. (US) | 2022-07-20 | — | — | EP | disclosed |
| US-11312793-B2 | Amino-quinone antipolymerants and methods of using | ECOLAB USA INC. (US) | 2022-04-26 | — | — | US | disclosed |
| US-11271237-B2 | Organic redox molecules for flow batteries | UCHICAGO ARGONNE, LLC (US) | 2022-03-08 | — | — | US | disclosed |
| US-20150192852-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PLATE MAKING METHOD | FUJIFILM CORPORATION (JP) | 2015-07-09 | — | — | US | disclosed |
| US-8846674-B2 | Nitric oxide enhancing prostaglandin compounds, compositions and methods of use | NICOX, S.A. (FR) | 2014-09-30 | — | — | US | disclosed |
| WO-2014126663-A1 | ONLINE MONITORING OF POLYMERIZATION INHIBITORS FOR CONTROL OF UNDESIRABLE POLYMERIZATION | ECOLAB USA INC. (US) | 2014-08-21 | — | — | WO | disclosed |
| US-20140228604-A1 | ONLINE MONITORING OF POLYMERIZATION INHIBITORS FOR CONTROL OF UNDESIRABLE POLYMERIZATION | ECOLAB USA INC. (US) | 2014-08-14 | — | — | US | disclosed |
| US-20120034321-A1 | NITRIC OXIDE ENHANCING PROSTAGLANDIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. | 2012-02-09 | — | — | US | disclosed |
| US-8067414-B2 | Nitric oxide enhancing prostaglandin compounds, compositions and methods of use | NICOX S.A. (FR) | 2011-11-29 | — | — | US | disclosed |
| US-20100240622-A1 | NITRIC OXIDE ENHANCING PROSTAGLANDIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2010-09-23 | — | — | US | disclosed |
| US-20080280890-A1 | HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE | COLBY PHARMACEUTICAL COMPANY | 2008-11-13 | — | — | US | disclosed |
| US-20080280890-A1 | HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE | COLBY PHARMACEUTICAL COMPANY | 2008-11-13 | — | — | US | disclosed |
| EP-1186588-A1 | 6-HYDROXY-2-NAPHTHYLCARBINOL AND PROCESS FOR THE PREPARATION THEREOF | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140228604-A1 | ONLINE MONITORING OF POLYMERIZATION INHIBITORS FOR CONTROL OF UNDESIRABLE POLYMERIZATION | PPOX, NOX4, NOX1 | GAA 1483/4885L3MBTL1 1849/4885HTT 1457/4885 |
| US-20100240622-A1 | NITRIC OXIDE ENHANCING PROSTAGLANDIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE | PTGIS, NOS2, NOS1 | GAA 2233/4885L3MBTL1 4855/4885HTT 2357/4885 |
| US-11866631-B2 | Oxygenated aminophenol compounds and methods for preventing monomer polymerization | HPD, DNPEP, PAH | GAA 1858/4885L3MBTL1 3743/4885HTT 695/4885 |
| US-20260103650-A1 | THERMALLY STABLE COMPOSITIONS AND USE THEREOF AS ANTIFOULANTS | ADH1A, ADH5, ADH1C | GAA 4307/4885L3MBTL1 726/4885HTT 1143/4885 |
| US-11396629-B2 | Quinone methide and ammonium salt antipolymerant composition and method | SQOR, QDPR, NQO2 | GAA 1088/4885L3MBTL1 4518/4885HTT 226/4885 |
| US-20120034321-A1 | NITRIC OXIDE ENHANCING PROSTAGLANDIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE | PTGIS, NOS2, PTGS1 | GAA 2755/4885L3MBTL1 4875/4885HTT 3144/4885 |
| US-11271237-B2 | Organic redox molecules for flow batteries | GPX1, LPO, GPX4 | GAA 2689/4885L3MBTL1 4512/4885HTT 4855/4885 |
| US-20080280890-A1 | HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE | HDGF, HMOX1, HMOX2 | GAA 3200/4885L3MBTL1 4642/4885HTT 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.